(Press-News.org) About 80% of people have the fungus Candida albicans in their gut. Although most of the time it persists unnoticed for years causing no health problems, C. albicans can turn into a dangerous microbe that causes serious diseases in many organs, including the urinary tract, lungs and brain. Understanding how this fungus colonizes the gut is key to preventing it from becoming harmful.
Working with a mouse model, researchers at Baylor College of Medicine and international collaborators have discovered unexpected factors that help C. albicans settle and persist in the gut. The findings expand our knowledge of the fungus-gut interactions and offer potential solutions to reduce colonization. The study appeared in Microbiology Spectrum.
“Our study revealed unexpected findings,” said first author Kelsey Mauk, a graduate student in the lab of Dr. David Corry at Baylor. “Most previous studies were conducted in mice that had been treated with antibiotics or drugs to suppress the immune system before introducing C. albicans. The assumption was that infection would not be possible without those treatments.”
Mauk, Corry and their colleagues explored how C. albicans colonizes the gut under healthy, unmodified conditions, which reflect real-life scenarios. They were expecting that C. albicans would not be able to colonize the animal’s gut. To their surprise, they found that a clinical strain, called CLCA10, could persist in the mouse gut for at least 58 days without causing weight loss, inflammation or disrupting the gut’s bacterial balance. Furthermore, treatment with anti-fungal medication reduced, but did not eliminate the fungus.
The fungus remained mostly associated with the gut’s contents and the mucus layer. In healthy mice, other human-associated fungal species did not colonize the gut, suggesting that something different about C. albicans affected its ability to establish itself in the gut.
The researchers were expecting to identify factors in the mouse, such as sex, diet or commercial source, that would influence the ability of C. albicans to colonize. “It turned out that none of these factors affected the ability of the fungus to establish itself in the gut,” Mauk said. “C. albicans can make itself at home under many different conditions.”
The team also expected that factors linked to C. albicans, such as the production of a short protein or peptide toxin called candidalysin, would not favor colonization. Candidalysin is a major contributor to C. albicans virulence. This toxin is secreted by C. albicans hyphae, a thread-like form of the fungus; it damages host cells and triggers inflammatory immune responses.
“We thought that candidalysin would not contribute to C. albicans colonization because it triggers strong responses in the gut,” Mauk said. “The experiments blew away our expectations. It turned out that candidalysin as well as two other hypha-associated proteins – adhesins Als3 and Hwp1– were necessary for the fungus to take root and persist in the gut. Mice infected with strains lacking these proteins had much lower levels of fungal colonization.”
“This study shows that C. albicans gut colonization in the mouse is critically dependent on fungal hyphal factors,” said Corry, Fulbright Endowed Chair in Pathology, Immunology and Medicine and member of the Dan L Duncan Comprehensive Cancer Center at Baylor. “Therapeutically targeting these factors could enhance strategies to reduce C. albicans gut colonization and the intractable threat to human health it represents.”
Other contributors to this work include Pedro Miramón, Michael C. Lorenz, Léa Lortal, Julian R. Naglik, Bernhard Hube, Lynn Bimler and Farrah Kheradmand. The authors are affiliated with one or more of the following institutions: Baylor College of Medicine, the University of Texas Health Science Center at Houston, King’s College London, Hans Knoell Institute in Germany,
Friedrich Schiller University Jena in Germany and Michael E. DeBakey VA Medical Center in Houston.
This research is supported by the National Institutes of Health grants (NIH) HL140398, R01AI135803, 1K01AG083119, 1T32HL139425, DE022550 and 5T32HL007747 and the National Institute of General Medical Sciences of the NIH under Award Number T32GM136554. Further support was provided by the Wellcome Trust (grant 214229_Z_18_Z).
###
END
Recent climate-related crises — from severe storms and flooding to extreme heat — have raised new questions about how local governments communicate the risk of these crises and what they are doing to keep their citizens safe. To better understand what this communication looks like at local level, and the factors that may be shaping it, researchers from Drexel University analyzed climate resilience planning information available on the public-facing websites of 24 coastal communities in New Jersey that are contending with the effects of sea level rise. Their report, recently published in the Journal of Extreme Events, ...
A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman’s personalized five-year risk of developing breast cancer has received Breakthrough Device designation from the Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, the software has been licensed to Prognosia Inc., a WashU startup company.
The system analyzes mammograms to produce a risk score estimating the likelihood that a woman will develop breast cancer over the next five years. The technology is ...
True or false?
“It is safe to take an over-the-counter medicine to help you sleep, even if you are drunk on alcohol.”
“Driving while high on THC (cannabis) is safe.”
“Using psychedelics is safe for everyone.”
None of those statements is true. But young men who take a passive approach to news and information—consuming whatever flows over their social media transoms—were likely to believe them in a national survey conducted by Washington State ...
The University of Copenhagen is excited to announce Zuber Lawler as a Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
“Zuber Lawler demonstrates meticulous attention to detail with a client-first mentality… They offer personalized care from highly intelligent and creative counsel… ...
Decades ago, archaeologists discovered a sticky substance in a copper jar in an ancient Greek shrine. And until recently, the identity of the residue was still murky — is it a mixture of fats, oils and beeswax or something else? Researchers publishing in the Journal of the American Chemical Society have reanalyzed samples of the residue using modern analytical techniques and determined that it’s likely the remains of ancient honey — a conclusion previous analyses rejected.
Honey was an important substance in the ancient world, sometimes left in shrines as offerings ...
The COVID-19 pandemic has placed enormous pressure on healthcare systems and economies around the world, with particularly severe impacts on vulnerable groups like residents of long-term care facilities (LTCFs). One key lesson from the pandemic is that early detection and treatment can lower hospitalization and death rates while also cutting medical costs. Wastewater surveillance at treatment plants (WSTPs) has emerged as a low-cost and innovative method to detect outbreaks early. Many developed countries have adopted this approach, ...
The University of Copenhagen is excited to announce Deep Origin as the latest tier 3 sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
Deep Origin is building hybrid mechanistic, physics and AI-based models that help researchers design, test, and filter therapeutics in silico – particularly for challenging disease areas such as aging. ...
Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the journal Nature Communications. The surge of energy is the first reported instance of a defensive mechanism which helps the cells repair DNA damage and survive the crowded environments of the human body.
The findings help explain how cancer cells survive complex mechanical gauntlets like crawling through a tumour microenvironment, sliding into porous blood vessels or enduring the battering of the bloodstream. The discovery of the ...
A huge flood triggered by the rapid draining of a lake beneath the Greenland ice sheet occurred with such force that it fractured the ice above and burst out across its surface.
This phenomenon, observed for the first time in Greenland and detailed in research published today in the journal Nature Geoscience, sheds new light on the destructive potential of meltwater stored beneath the ice sheet.
It reveals how, under extreme conditions, water flooding underneath the ice can force its way upwards through the ice and escape at the ice sheet surface.
This phenomenon is not considered by numerical models ...
The cerebral cortex processes sensory information via a complex network of neural connections. How are these signals modulated to refine perception? A team from the University of Geneva (UNIGE) has identified a mechanism by which certain thalamic projections target neurons and modify their excitability. This work, published in Nature Communications, reveals a previously unknown form of communication between two regions of the brain, the thalamus and the somatosensory cortex. It could explain why the same sensory stimulus does not always elicit the same sensation ...
